Efficacy and safetyof different p-blockers in patients with isolated systolic hypertension, associated with diabetes mellitus and obstructive pulmonary diseases
- Authors: Kukes VG1, Ostroumova OD1, Mamaev VI1, Batutina AM1, Abakumov Y.E1, Zykova AA1
-
Affiliations:
- ММА им. И. М. Сеченова, МГМСУ
- Issue: Vol 78, No 8 (2003)
- Pages: 43-48
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/33368
- ID: 33368
Cite item
Full Text
Abstract
in patients with isolated systolic arterial hypertension (ISAH) and concomitant diabetes mellitus (DM)
and/or chronic obstructive pulmonary disease (COPD).
Material and methods. Forty two patients with ISAH and coronary heart disease, 30 patients with
these diseases associated with DM and 32 patients with associated COPD were randomized into three
groups. Group 1 received atenolol in a dose 25 mg twice a day, group 2 - metoprolol tartrate in a
dose 25-50 mg twice a day, group 3 - bisoprolol in a single dose 5-10 mg/day. All the patients
were examined before the treatment and in 8 weeks. Arterial pressure was assessed at 24-h monitoring
(ABPM-04 unit, Mediteck, Hungary) and quality of life (QL) was estimated by DISS Disability
Scale. In addition, blood glucose was measured in patients with concomitant DM, external respiration
function (ERF) was studied before and after the treatment in patients with concomitant COPD.
Results. In all ISAH patients there was a significant fall of systolic arterial pressure and heart rate. 2
hours after intake of atenolol and methoprolol blood glucose lowered significantly in diabetics as well
as peak volume expiration velocity in patients with COPD. In the bisoprolol group ERF and blood glucose
in DM and COPD patients remained unchanged. Atenolol deteriorated QL by the "job" and "social life"scales,
methoprolol - by the scale "job" while bisoprolol improved the above parameters.
Conclusion. The results of bisoprolol treatment are better than those of methoprolol and atenolol treatment
of hypertensive patients with concomitant DM and COPD.
About the authors
V G Kukes
ММА им. И. М. Сеченова, МГМСУММА им. И. М. Сеченова, МГМСУ
O D Ostroumova
ММА им. И. М. Сеченова, МГМСУММА им. И. М. Сеченова, МГМСУ
V I Mamaev
ММА им. И. М. Сеченова, МГМСУММА им. И. М. Сеченова, МГМСУ
A M Batutina
ММА им. И. М. Сеченова, МГМСУММА им. И. М. Сеченова, МГМСУ
Yu E Abakumov
ММА им. И. М. Сеченова, МГМСУММА им. И. М. Сеченова, МГМСУ
A A Zykova
ММА им. И. М. Сеченова, МГМСУММА им. И. М. Сеченова, МГМСУ
References
- Luomanmaki К., Inkovaara J., Hartikalnen M. Efficacy and tolerability of isradipine and metoprolol in treatment of hypertension, the Finnish Isradipin Study in Hypertension (FISH).J. Cardiovasc. Pharmacol. 1992; 20: 296-303.
- Hedblad В., Wikstrand J., Jabzon L. et al. Low-dose, metoprolol CR/XL and fluvastatin slow progression of carotid intimamedia thickness: main results from the p-blocker cholesterollowering asymptomatic plaque study (BCAPS). Circulation 2001; 103: 1721-1726.
- Waagstein F., Bristow M. R., Swedberg K. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1441-1446.
- Cruickshank A. Beta-blockers continue to surprise us. Eur. Heart. J. 2000; 21: 354-364.
- Wellstein A. et al. Concentration kinetics of propranolol, bisoprolol and atenolol in humans assessed with chemical detection and a subtype selective adrenoreceptor. J. Cardiovasc. Pharmacol. 1986; 8(suppl.): 41.
- Ольбинская Л. И., Мартынов А. И., Хапаев Б. А. Мониторирование артериального давления в кардиологии. М.: ММСИ; 1998. 26-32.
- Тапит L., Malt U. F. A new pharmacologic treatment of functional gastrointestinal disorders. Scand. J. Gastroenterol. 1996; 31: 318-325.
- Breed J. C., Ciampricotti R., Tromp G. P. et al. Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril. J. Cardiovasc. Pharmacol. 1992; 20: 750-755.
- Perry H. M., Hall W. D., Benz J. et al. Efficacy and safety of atenolol, enalapril and isradipine in elderly hypertensive women. Am. J. Med. 1994; 96(1): 77-86.
- Croog S. H., Elias M. F., Colton T. Effects of antihypertensive medications on quality of life in elderly hypertensive women.Am. J. Hypertens. 1994; 7: 329-339.
- Lichtman J. H., Krumholz H. M., Yun Wang. Risk and predictors of stroke after myocardial infarction among the elderly: results from the cooperative cardiovascular project. Circulation 2002; (3): 1082-1087.
- Chatterjee S. S. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. J. Cardiovasc. Pharmacol. 1986; 8: 74-77.
- Dorow P., Bethge H., Tonnesmann I. Effects of singl oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. Eur. J. Clin. Pharmacol. 1986; 31: 143-147.
- King H., Auberg R. E., Herman W. H. Global burden of diabetes 1995-2025: prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-1431.
- Fagan T. C., Sowers J. Type 2 diabetes mellitus. Greater cardiovascular risks and greater benefits of therapy. Arch. Intern. Med. 1999; 159: 1033-1034.
- Hypertention in Diabetes Study Group. Hypertention in diabetes study IV. Therapeutic requirements to maintain tight blood pressure control. Diabetologia 1995; 39: 1554-1561.
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
- UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39, Br. Med. J. 1998; 317: 713-720.
- Tse W. Y., Kendall M. Is there a role for beta-blockers in hypertensive diabetic patients? Diabet. Med. 1994; 11: 137-144.
- Janka H. U., Ziegler A. G., Disselhoff G., Mehnert H. Influence of bisoprolol on blood glucose, glucosuria, and haemoglobin Al in noninsulin-dependent daibetics. J. Cardiovasc. Pharmacol. 1986; 8: 96-99.
- Broekman С. P., Hawnsel S. M., Van de Ven L. L., Slob A. K. Bisoprolol and hypertension: effects on sexual functioning in men. J. Sex. Marital Ther. 1992; 18(4): 325-331.
- Bulpitt С. J., Connor M., Schulte M. et al. Bisoprolol and nifedipine retard in elderly hypertensive patients; effect on quality of life. J. Hum. Hypertens. 2000; 14: 205-212.
- Bracchetti D. et al. A double-blind comparison of bisoprolol and captopril for treatment of essential hypertention in the elderly. Cardiovasc. Drug. Ther. 1990; 4: 261.
![](/img/style/loading.gif)